Amro A. Albanna
Net Worth

Last updated:

What is Amro A. Albanna net worth?

The estimated net worth of Mr. Amro A. Albanna is at least $1,008,001 as of 19 Jul 2022. He owns shares worth $1 as insider and has received compensation worth at least $1,008,000 in Aditxt, Inc..

What is the salary of Amro A. Albanna?

Mr. Amro A. Albanna salary is $252,000 per year as Co-Founder, Chairman & Chief Executive Officer in Aditxt, Inc..

How old is Amro A. Albanna?

Mr. Amro A. Albanna is 55 years old, born in 1970.

What stocks does Amro A. Albanna currently own?

As insider, Mr. Amro A. Albanna owns shares in one company:

Company Title Shares Price per share Total value
Aditxt, Inc. (ADTX) Co-Founder, Chairman & Chief Executive Officer 1 $1.11 $1

What does Aditxt, Inc. do?

Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.

ADTX logo
ADTX
Aditxt, Inc.
$1.11

Amro A. Albanna insider trading

Aditxt, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Series B Preferred Stock 1 $20,000 $20,000
Purchase
Common Stock 3,400 $2.92 $9,942
Purchase
Common Stock 3,400 $2.92 $9,942

Aditxt key executives

Aditxt, Inc. executives and other stock owners filed with the SEC:

  • Dr. Shahrokh Shabahang D.D.S., M.S., Ph.D. (62) Co-Founder, Chief Innovation Officer, Sec. & Director
  • Mr. Amro A. Albanna (55) Co-Founder, Chairman & Chief Executive Officer
  • Ms. Corinne D. Pankovcin CPA, CPA, M.B.A. (59) Pres